Diploma (LON:DPLM) Shares Up 15.1% – What’s Next?

Diploma PLC (LON:DPLM) traded up 15.1% during mid-day trading on Tuesday . The stock traded as high as GBX 5,025 ($67.30) and last traded at GBX 4,860 ($65.09). 975,747 shares were traded during mid-day trading, an increase of 115% from the average session volume of 453,933 shares. The stock had previously closed at GBX 4,222 ($56.54).

Diploma Stock Up 0.0%

The firm’s 50-day moving average price is GBX 3,949.28 and its 200 day moving average price is GBX 4,253.28. The firm has a market capitalization of £6.49 billion, a price-to-earnings ratio of 55.89, a price-to-earnings-growth ratio of 2.82 and a beta of 0.75. The company has a debt-to-equity ratio of 62.17, a current ratio of 2.17 and a quick ratio of 0.80.

Diploma (LON:DPLM) last posted its earnings results on Wednesday, May 21st. The company reported GBX 80.20 ($1.07) earnings per share (EPS) for the quarter. Diploma had a return on equity of 13.18% and a net margin of 9.25%. Sell-side analysts expect that Diploma PLC will post 163.7995512 EPS for the current year.

Insider Transactions at Diploma

In other Diploma news, insider David S. Lowden acquired 750 shares of the firm’s stock in a transaction dated Friday, March 21st. The shares were acquired at an average price of GBX 3,928 ($52.60) per share, for a total transaction of £29,460 ($39,453.60). Also, insider Ian El-Mokadem acquired 500 shares of the stock in a transaction dated Monday, March 24th. The stock was acquired at an average cost of GBX 3,948 ($52.87) per share, with a total value of £19,740 ($26,436.32). Insiders own 0.52% of the company’s stock.

Diploma Company Profile

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.